litlas
ログインアカウント作成

Antonio Omuro

2005–2025 年に発表

別表記
Antonio, Omuro
83
論文数
26,426
被引用数
62
h 指数
79
i10 指数

被引用数

Antonio Omuro の年別被引用数1976 年: 被引用 1 件1977 年: 被引用 1 件1986 年: 被引用 1 件1992 年: 被引用 2 件1998 年: 被引用 1 件2004 年: 被引用 1 件2005 年: 被引用 4 件2006 年: 被引用 15 件2007 年: 被引用 24 件2008 年: 被引用 29 件2009 年: 被引用 51 件2010 年: 被引用 40 件2011 年: 被引用 36 件2012 年: 被引用 35 件2013 年: 被引用 60 件2014 年: 被引用 76 件2015 年: 被引用 111 件2016 年: 被引用 120 件2017 年: 被引用 241 件2018 年: 被引用 347 件2019 年: 被引用 1,142 件2020 年: 被引用 1,619 件2021 年: 被引用 1,733 件2022 年: 被引用 1,336 件2023 年: 被引用 1,097 件2024 年: 被引用 1,582 件2025 年: 被引用 676 件2026 年: 被引用 29 件1978〜1985 年は被引用が無いため表示していません1987〜1991 年は被引用が無いため表示していません1993〜1997 年は被引用が無いため表示していません1999〜2003 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,023 件、この内訳の 29.3%中国: 引用元論文 2,093 件、この内訳の 15.3%ドイツ: 引用元論文 756 件、この内訳の 5.5%イタリア: 引用元論文 667 件、この内訳の 4.9%イギリス: 引用元論文 615 件、この内訳の 4.5%フランス: 引用元論文 511 件、この内訳の 3.7%カナダ: 引用元論文 456 件、この内訳の 3.3%日本: 引用元論文 388 件、この内訳の 2.8%オランダ: 引用元論文 378 件、この内訳の 2.8%スペイン: 引用元論文 364 件、この内訳の 2.7%スイス: 引用元論文 356 件、この内訳の 2.6%オーストラリア: 引用元論文 294 件、この内訳の 2.1%
0%29.3%その他 20.5%

機関

分野

  • Medicine62.9%
  • Biochemistry, Genetics and Molecular Biology26%
  • Immunology and Microbiology5.5%
  • Neuroscience1.8%
  • Computer Science1.3%
  • Engineering1.1%
  • その他1.4%

トピック

  • Glioma Diagnosis and Treatment9%
  • Cancer Immunotherapy and Biomarkers7%
  • Cancer Genomics and Diagnostics6.4%
  • Lung Cancer Treatments and Mutations3%
  • Brain Metastases and Treatment2.8%
  • Immune cells in cancer2.6%
  • その他69.2%

共著者

全論文

検索で開く
  1. Tumor mutational load predicts survival after immunotherapy across multiple cancer types

    著者: Robert Samstein, Chung‐Han Lee, Alexander N. Shoushtari, Matthew D. Hellmann, Ronglai Shen, Yelena Y. Janjigian, David Barron, Ahmet Zehir, Emmet Jordan, Antonio Omuro, Thomas Kaley, Sviatoslav M. Kendall, Robert J. Motzer, A. Ari Hakimi, Martin H. Voss, Paul Russo, Jonathan E. Rosenberg, Gopa Iyer, Bernard H. Bochner, Dean F. Bajorin, Hikmat Al‐Ahmadie, Jamie E. Chaft, Charles M. Rudin, Gregory J. Riely, Shrujal S. Baxi, Alan L. Ho, Richard J. Wong, David G. Pfister, Jedd D. Wolchok, Christopher A. Barker, Philip H. Gutin, Cameron Brennan, Viviane Tabar, Ingo K. Mellinghoff, Lisa M. DeAngelis, Charlotte E. Ariyan, Nancy Y. Lee, William D. Tap, Mrinal M. Gounder, Sandra P. D’Angelo, Leonard B. Saltz, Zsofia K. Stadler, Howard I. Scher, José Baselga, Pedram Razavi, Christopher A. Klebanoff, Rona Yaeger, Neil H. Segal, Geoffrey Y. Ku, Ronald P. DeMatteo, Marc Ladanyi, Naiyer A. Rizvi, Michael F. Berger, Nadeem Riaz, David B. Solit, Timothy A. Chan, Luc G.T. Morris - Nature Genetics 2019 被引用: 4,358

  2. OncoKB: A Precision Oncology Knowledge Base

    著者: Debyani Chakravarty, Jianjiong Gao, Sarah Phillips, Ritika Kundra, Hongxin Zhang, Jiaojiao Wang, Julia E. Rudolph, Rona Yaeger, Tara E. Soumerai, Moriah H. Nissan, Matthew T. Chang, Sarat Chandarlapaty, Tiffany A. Traina, Paul K. Paik, Alan L. Ho, Feras Hantash, Andrew Grupe, Shrujal S. Baxi, Margaret K. Callahan, Alexandra Snyder, Ping Chi, Daniel C. Danila, Mrinal M. Gounder, James J. Harding, Matthew D. Hellmann, Gopa Iyer, Yelena Y. Janjigian, Thomas Kaley, Douglas A. Levine, Maeve A. Lowery, Antonio Omuro, Michael A. Postow, Dana E. Rathkopf, Alexander N. Shoushtari, Neerav Shukla, Martin H. Voss, Ederlinda Paraiso, Ahmet Zehir, Michael F. Berger, Barry S. Taylor, Leonard B. Saltz, Gregory J. Riely, Marc Ladanyi, David M. Hyman, José Baselga, Paul Sabbatini, David B. Solit, Nikolaus Schultz - JCO Precision Oncology 2017 被引用: 2,698

  3. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

    著者: Ahmet Zehir, Ryma Benayed, Ronak Shah, Aijazuddin Syed, Sumit Middha, Hyunjae R. Kim, Preethi Srinivasan, Jianjiong Gao, Debyani Chakravarty, Sean M. Devlin, Matthew D. Hellmann, David Barron, Alison M. Schram, Meera Hameed, Snjezana Doğan, Dara S. Ross, Jaclyn F. Hechtman, Deborah F. DeLair, JinJuan Yao, Diana Mandelker, Donavan T. Cheng, Raghu Chandramohan, Abhinita Mohanty, Ryan Ptashkin, Gowtham Jayakumaran, Meera Prasad, Mustafa Syed, Anoop Balakrishnan Rema, Zhen Y. Liu, Khédoudja Nafa, Laetitia Borsu, Justyna Sadowska, Jacklyn Casanova, Ruben Bacares, Iwona Kiecka, Anna Razumova, Julie B Son, Lisa Stewart, Tessara Baldi, Kerry Mullaney, Hikmat Al‐Ahmadie, Efsevia Vakiani, Adam Abeshouse, Alexander Penson, Philip Jonsson, Niedzica Camacho, Matthew T. Chang, Helen Won, Benjamin Groß, Ritika Kundra, Zachary Heins, Hsiao‐Wei Chen, Sarah Phillips, Hongxin Zhang, Jiaojiao Wang, Angelica Ochoa, Jonathan Wills, Michael Eubank, Stacy B. Thomas, Stuart M. Gardos, Dalicia N. Reales, Jesse Galle, Robert Durany, Roy Cambria, Wassim Abida, Andrea Cercek, Darren R. Feldman, Mrinal M. Gounder, A. Ari Hakimi, James J. Harding, Gopa Iyer, Yelena Y. Janjigian, Emmet Jordan, Ciara M. Kelly, Maeve A. Lowery, Luc G.T. Morris, Antonio Omuro, Nitya Raj, Pedram Razavi, Alexander N. Shoushtari, Neerav Shukla, Tara E. Soumerai, Anna M. Varghese, Rona Yaeger, Jonathan Coleman, Bernard H. Bochner, Gregory J. Riely, Leonard B. Saltz, Howard I. Scher, Paul Sabbatini, Mark E. Robson, David S. Klimstra, Barry S. Taylor, José Baselga, Nikolaus Schultz, David M. Hyman, Maria E. Arcila, David B. Solit, Marc Ladanyi, Michael F. Berger - Nature Medicine 2017 被引用: 3,517

  4. Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma

    著者: David A. Reardon, Alba A. Brandes, Antonio Omuro, Paul Mulholland, Michael Lim, Antje Wick, Joachim M. Baehring, Manmeet S. Ahluwalia, Patrick Roth, Oliver Bähr, Surasak Phuphanich, Juan Manuel Sepúlveda-Sánchez, Paul de Souza, Solmaz Sahebjam, Michael Carleton, Kay Tatsuoka, Corina Taitt, Ricardo Zwirtes, John H. Sampson, Michael Weller - JAMA Oncology 2020 被引用: 1,457

  5. Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter

    著者: Michael Lim, Michael Weller, Ahmed Idbaïh, Joachim P. Steinbach, Gaetano Finocchiaro, Raju R. Raval, George Ansstas, Joachim M. Baehring, Jennie Taylor, Jérôme Honnorat, Kevin Petrecca, Filip De Vos, Antje Wick, Ashley Sumrall, Solmaz Sahebjam, Ingo K. Mellinghoff, Masashi Kinoshita, Mustimbo Roberts, Ruta Slepetis, Deepti Warad, David Leung, Michelle H. Lee, David A. Reardon, Antonio Omuro - Neuro-Oncology 2022 被引用: 501

  6. Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial

    著者: Antonio Omuro, Alba A. Brandes, Alain Carpentier, Ahmed Idbaïh, David A. Reardon, Timothy F. Cloughesy, Ashley Sumrall, Joachim M. Baehring, Martin J. van den Bent, Oliver Bähr, Giuseppe Lombardi, Paul Mulholland, Ghazaleh Tabatabai, Ulrik Lassen, Juan Manuel Sepúlveda-Sánchez, Mustafa Khasraw, Élodie Vauléon, Yoshihiro Muragaki, Anna Maria Di Giacomo, Nicholas Butowski, Patrick Roth, Xiaozhong Qian, Alex Z. Fu, Yanfang Liu, Von Potter, Alexandros-Georgios Chalamandaris, Kay Tatsuoka, Michael Lim, Michael Weller - Neuro-Oncology 2022 被引用: 485

  7. Glioblastoma and Other Malignant Gliomas

    著者: Antonio Omuro - JAMA 2013 被引用: 2,304

  8. Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study

    著者: Nicholas Butowski, Howard Colman, John de Groot, Antonio Omuro, Lakshmi Nayak, Patrick Y. Wen, Timothy F. Cloughesy, Adhirai Marimuthu, Sam Haidar, Arie Perry, Jason T. Huse, Joanna J. Phillips, Brian L. West, K. B. Nolop, Henry H. Hsu, Keith L. Ligon, Annette M. Molinaro, Michael D. Prados - Neuro-Oncology 2015 被引用: 580

  9. Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143

    著者: Antonio Omuro, Gordana Vlahovic, Michael Lim, Solmaz Sahebjam, Joachim M. Baehring, Timothy F. Cloughesy, Alfredo Voloschin, Shakti Ramkissoon, Keith L. Ligon, Robert Latek, Ricardo Zwirtes, Lewis C. Strauss, Prashni Paliwal, Christopher Harbison, David A. Reardon, John H. Sampson - Neuro-Oncology 2017 被引用: 488

  10. Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid

    著者: Elena Pentsova, Ronak Shah, Jiabin Tang, Adrienne Boire, Daoqi You, Samuel Briggs, Antonio Omuro, Xuling Lin, Martin Fleisher, Christian Grommes, Katherine S. Panageas, Fanli Meng, S. Duygu Selçuklu, Shahiba Ogilvie, Natalie M. DiStefano, Larisa Shagabayeva, Marc K. Rosenblum, Lisa M. DeAngelis, Agnès Viale, Ingo K. Mellinghoff, Michael F. Berger - Journal of Clinical Oncology 2016 被引用: 437

  11. Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma

    著者: Christian Grommes, Alessandro Pastore, Nicolaos Palaskas, Sarah Tang, Carl Campos, Derrek Schartz, Paolo Codega, Donna Nichol, Owen Clark, Wan-Ying Hsieh, Dan Rohle, Marc K. Rosenblum, Agnès Viale, Viviane Tabar, Cameron Brennan, Igor T. Gavrilovic, Thomas Kaley, Craig Nolan, Antonio Omuro, Elena Pentsova, Alissa A. Thomas, Elina Tsyvkin, Ariela Noy, M. Lia Palomba, Paul A. Hamlin, Craig S. Sauter, Craig H. Moskowitz, J. M. Wolfe, Ahmet Doǧan, Minhee Won, Jon Glass, Scott Peak, Enrico C. Lallana, Vaios Hatzoglou, Anne S. Reiner, Philip H. Gutin, Jason T. Huse, Katherine S. Panageas, Thomas G. Graeber, Nikolaus Schultz, Lisa M. DeAngelis, Ingo K. Mellinghoff - Cancer Discovery 2017 被引用: 402

  12. Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial

    著者: Patrick Y. Wen, Mehdi Touat, Brian M. Alexander, Ingo K. Mellinghoff, Shakti Ramkissoon, Christine McCluskey, Kristine Pelton, Sam Haidar, Sankha S. Basu, Sarah Gaffey, Loreal Brown, Juan Emmanuel Martinez-Ledesma, Shaofang Wu, Jung-Woo Kim, Wei Wei, Mi‐Ae Park, Jason T. Huse, John G. Kuhn, Mikael L. Rinne, Howard Colman, Nathalie Y.R. Agar, Antonio Omuro, Lisa M. DeAngelis, Mark R. Gilbert, John de Groot, Timothy F. Cloughesy, Andrew Chi, Thomas M. Roberts, Jean J. Zhao, Eudocia Q. Lee, Lakshmi Nayak, James R. Heath, Laura L. Horky, Tracy T. Batchelor, Rameen Beroukhim, Susan M. Chang, Azra H. Ligon, Ian F. Dunn, Dimpy Koul, Geoffrey S. Young, Michael D. Prados, David A. Reardon, W.K. Alfred Yung, Keith L. Ligon - Journal of Clinical Oncology 2019 被引用: 155

  13. Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas

    著者: Philip Jonsson, Andrew Lin, Robert J. Young, Natalie M. DiStefano, David M. Hyman, Bob T. Li, Michael F. Berger, Ahmet Zehir, Marc Ladanyi, David B. Solit, Angela G. Arnold, Zsofia K. Stadler, Diana Mandelker, Michael E. Goldberg, Juliann Chmielecki, Maryam Pourmaleki, Shahiba Ogilvie, Shweta S. Chavan, Andrew T. McKeown, Malbora Manne, Allison Hyde, Kathryn Beal, Jonathan T. Yang, Craig Nolan, Elena Pentsova, Antonio Omuro, Igor T. Gavrilovic, Thomas Kaley, Eli L. Diamond, Jacqueline Stone, Christian Grommes, Adrienne Boire, Mariza Daras, Anna F. Piotrowski, Alexandra Miller, Philip H. Gutin, Timothy A. Chan, Viviane Tabar, Cameron Brennan, Marc K. Rosenblum, Lisa M. DeAngelis, Ingo K. Mellinghoff, Barry S. Taylor - Clinical Cancer Research 2019 被引用: 156

  14. R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma

    著者: Antonio Omuro, Denise D. Correa, Lisa M. DeAngelis, Craig H. Moskowitz, Matthew J. Matasar, Thomas Kaley, Igor T. Gavrilovic, Craig Nolan, Elena Pentsova, Christian Grommes, Katherine S. Panageas, Raymond E. Baser, Géraldine Faivre, Lauren E. Abrey, Craig S. Sauter - Blood 2015 被引用: 345

  15. Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo

    著者: Sriram Venneti, Mark Dunphy, Hanwen Zhang, Kenneth L. Pitter, Patrick Zanzonico, Carl Campos, Sean D. Carlin, Gaspare La Rocca, Serge K. Lyashchenko, Karl Plöessl, Daniel Rohle, Antonio Omuro, Justin R. Cross, Cameron Brennan, Wolfgang Weber, Eric C. Holland, Ingo K. Mellinghoff, Hank F. Kung, Jason S. Lewis, Craig B. Thompson - Science Translational Medicine 2015 被引用: 304

  16. Nivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: Results from exploratory phase I cohorts of CheckMate 143

    著者: Antonio Omuro, David A. Reardon, John H. Sampson, Joachim M. Baehring, Solmaz Sahebjam, Timothy F. Cloughesy, Alexandros-Georgios Chalamandaris, Von Potter, Nicholas Butowski, Michael Lim - Neuro-Oncology Advances 2022 被引用: 69

  17. Using Adversarial Images to Assess the Robustness of Deep Learning Models Trained on Diagnostic Images in Oncology

    著者: Marina Z. Joel, Sachin Umrao, Enoch Chang, Rachel Choi, Daniel X. Yang, James S. Duncan, Antonio Omuro, Roy Herbst, Harlan M. Krumholz, Sanjay Aneja - JCO Clinical Cancer Informatics 2022 被引用: 38

  18. Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome

    著者: Patrick G. Morris, Denise D. Correa, Joachim Yahalom, Jeffrey J. Raizer, David Schiff, Barbara Grant, Sean Grimm, Rose Lai, Anne S. Reiner, K. Panageas, Sasan Karimi, Richard Curry, Gaurav Shah, Lauren E. Abrey, Lisa M. DeAngelis, Antonio Omuro - Journal of Clinical Oncology 2013 被引用: 491

  19. Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors

    著者: Xuling Lin, Martin Fleisher, Marc K. Rosenblum, Oscar Lin, Adrienne Boire, Samuel Briggs, Yevgeniya Bensman, Brenda Hurtado, Larisa Shagabayeva, Lisa M. DeAngelis, Katherine S. Panageas, Antonio Omuro, Elena Pentsova - Neuro-Oncology 2017 被引用: 115

  20. OS10.3 Randomized Phase 3 Study Evaluating the Efficacy and Safety of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: CheckMate 143

    著者: David A. Reardon, Antonio Omuro, Alba A. Brandes, Johannes Rieger, Antje Wick, Juan Manuel Sepúlveda-Sánchez, Surasak Phuphanich, Paul de Souza, Manmeet S. Ahluwalia, Michael Lim, Gordana Vlahovic, John H. Sampson - Neuro-Oncology 2017 被引用: 327

  21. Machine Learning Applications for Differentiation of Glioma from Brain Metastasis—A Systematic Review

    著者: Leon Jekel, Waverly Rose Brim, Marc von Reppert, Lawrence H. Staib, Gabriel Cassinelli Petersen, Sara Merkaj, Harry Subramanian, Tal Zeevi, Seyedmehdi Payabvash, Khaled Bousabarah, MingDe Lin, Jin Cui, Alexandria Brackett, Amit Mahajan, Antonio Omuro, Michele H. Johnson, Veronica Chiang, Ajay Malhotra, Björn Scheffler, Mariam Aboian - Cancers 2022 被引用: 38

  22. Phase I dose-escalation study of the PI3K/mTOR inhibitor voxtalisib (SAR245409, XL765) plus temozolomide with or without radiotherapy in patients with high-grade glioma

    著者: Patrick Y. Wen, Antonio Omuro, Manmeet S. Ahluwalia, Hassan M. Fathallah‐Shaykh, Nimish Mohile, Joanne Lager, Alexander Laird, Jiali Tang, Jason Jiang, Coumaran Égile, Timothy F. Cloughesy - Neuro-Oncology 2015 被引用: 84

  23. Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer

    著者: Rachna Malani, Martin Fleisher, Priya Kumthekar, Xuling Lin, Antonio Omuro, Morris D. Groves, Nancy U. Lin, Michelle Melisko, Andrew B. Lassman, Suriya Jeyapalan, Andrew D. Seidman, Anna Skakodub, Adrienne Boire, Lisa M. DeAngelis, Marc K. Rosenblum, Jeffrey J. Raizer, Elena Pentsova - Journal of Neuro-Oncology 2020 被引用: 81

  24. Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2 -mutant Glioma

    著者: Kristina Fanucci, Mary Jo Pilat, Derek Shyr, Yu Shyr, Scott A. Boerner, Jing Li, Diane E. Durecki, Jan Drappatz, Vinay K. Puduvalli, Frank S. Lieberman, Javier Gonzalez, Pierre Giglio, S. Percy Ivy, Ranjit S. Bindra, Antonio Omuro, Patricia LoRusso - Cancer Research Communications 2023 被引用: 30